Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
HIV & AIDS
•
Primary Care
Do you routinely prescribe GLP-1 receptor agonists to people living with HIV (PLH) with obesity?
Nguyen Q, et al. PMID 38501237
Related Questions
What steps do you recommend to ensure continued viral suppression and prevent drug resistance in an HIV patient on injectable cabotegravir and rilpivirine who misses their scheduled injection appointment by two weeks?
How do you approach management for patient's with HIV on ART with persistent low level viremia but no new resistance mutations identified?
What patient-specific factors would influence your decision to initiate semaglutide therapy in patients with HIV-associated lipohypertrophy?
Do you recommend to continue acyclovir to prevent HSV infection in HIV patient with CD4 count more than 200 and with high viral load?
How do you use CD4% in clinical practice in management of patients living with HIV?
What is your approach to a positive PPD or IGRA in a patient with well-controlled HIV without significant TB risk factors?
Would you consider using long-acting injectable cabotegravir/rilpivirine for pregnant women with HIV?
How would you manage a patient with well controlled HIV on Biktarvy, who is interested in switching to injectable HAART but also has a history of a prior Hepatitis B Infection?
Do you routinely offer suppressive antibiotics to patients with a prosthetic joint infection when surgery is delayed for months?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
